Valuation: Enimmune corporation

Market Cap 1.16B 36.79M 32.09M 30.13M 27.54M 51.66M 3.52B 51.72M 361M 139M 1.79B 138M 135M 5.79B P/E 2024
-11.3x
P/E 2025 -9.04x
Enterprise Value 1.11B 35.07M 30.59M 28.72M 26.25M 49.24M 3.35B 49.29M 344M 133M 1.71B 132M 129M 5.52B EV / Sales 2024
35.4x
EV / Sales 2025 29.7x
Free-Float
28.72%
Yield 2024 *
-
Yield 2025 -
1 day-2.42%
1 week+5.56%
Current month-1.82%
1 month-2.12%
3 months-1.82%
6 months-6.10%
Current year-21.60%
1 week 15.05
Extreme 15.05
17.35
1 month 15.05
Extreme 15.05
17.35
Current year 14.9
Extreme 14.9
22.15
1 year 14.9
Extreme 14.9
23.9
3 years 14.65
Extreme 14.65
49.3
5 years 14.65
Extreme 14.65
75.3
10 years 14.49
Extreme 14.49
125
Manager TitleAgeSince
Chief Executive Officer - 07/01/2019
Chief Tech/Sci/R&D Officer - 21/07/2014
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Chairman - 07/01/2019
Director/Board Member - 02/01/2014
Director/Board Member - 19/05/2015
Change 5-day change 1-year change 3-year change Capi.($)
-2.42%+5.56%-21.98%-59.42% 37.6M
-0.07%+5.66%+54.34%+113.69% 74.33B
-1.45%-1.43%+36.82%+80.62% 62.26B
-0.66%+7.14%+39.36%+29.20% 27.72B
-0.15%-3.58%-16.54%+358.69% 26.42B
+2.93%+2.03%+4.83%-5.22% 24.62B
+0.84%+7.70%+26.09%-10.70% 20.72B
+0.87%-2.52%+151.81%+328.17% 15.01B
+1.63%+3.45%+45.01%+169.46% 14.18B
+1.30%-7.06%-9.37%+835.52% 13.48B
Average +0.28%+0.28%+31.04%+184.00% 27.88B
Weighted average by Cap. +0.09%+2.10%+37.43%+150.65%

Financials

2024 2025
Net sales 39.92M 1.26M 1.1M 1.03M 943K 1.77M 120M 1.77M 12.38M 4.78M 61.44M 4.73M 4.63M 198M 48.19M 1.52M 1.33M 1.25M 1.14M 2.14M 145M 2.14M 14.94M 5.77M 74.18M 5.72M 5.59M 240M
Net income -158M -4.98M -4.34M -4.08M -3.72M -6.99M -476M -6.99M -48.85M -18.86M -242M -18.68M -18.27M -783M -164M -5.19M -4.53M -4.25M -3.88M -7.29M -496M -7.3M -50.96M -19.67M -253M -19.49M -19.06M -817M
Net Debt -382M -12.06M -10.52M -9.88M -9.03M -16.94M -1.15B -16.96M -118M -45.73M -588M -45.3M -44.31M -1.9B -54.59M -1.72M -1.5M -1.41M -1.29M -2.42M -165M -2.42M -16.93M -6.54M -84.03M -6.47M -6.33M -271M
Logo Enimmune corporation
ENIMMUNE CORP. is a Taiwan-based biotechnology new drug company mainly engaged in the development, produce and distribution of new drugs. The Company's new drug products include biological agents, monoclonal antibodies, vaccines, and small molecule drugs. The Company mainly conducts drug testing business, biotechnology service business, international trade business, western medicine wholesale and retail business. The product is Tuberculin PPD.
Employees
-
Date Price Change Volume
22/09/26 NT$16.15 -2.42% 33,152
21/09/26 NT$16.55 0.00% 104,310
18/09/26 NT$16.55 -2.36% 36,113
17/09/26 NT$16.95 +0.89% 83,006
16/09/26 NT$16.80 +8.04% 184,271
  1. Stock Market
  2. Stocks
  3. 6564 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!